Roberta Olmo Pinheiro Selected Research

Multibacillary Leprosy

1/2022	The Type I Interferon Pathway Is Upregulated in the Cutaneous Lesions and Blood of Multibacillary Leprosy Patients With Erythema Nodosum Leprosum.
10/2021	A new paradigm for leprosy diagnosis based on host gene expression.
1/2018	Utility of immunoglobulin isotypes against LID-1 and NDO-LID for, particularly IgG1, confirming the diagnosis of multibacillary leprosy.
1/2018	Autophagy Impairment Is Associated With Increased Inflammasome Activation and Reversal Reaction Development in Multibacillary Leprosy.
1/2015	Correction: Correlation between Central Memory T Cell Expression and Proinflammatory Cytokine Production with Clinical Presentation of Multibacillary Leprosy Relapse.
1/2015	Correlation between Central Memory T Cell Expression and Proinflammatory Cytokine Production with Clinical Presentation of Multibacillary Leprosy Relapse.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roberta Olmo Pinheiro Research Topics

Disease

23	Leprosy (Hansen's Disease) 12/2022 - 11/2011
7	Infections 04/2022 - 10/2005
6	Multibacillary Leprosy 01/2022 - 01/2015
3	Inflammation (Inflammations) 01/2020 - 11/2011
3	Cutaneous Leishmaniasis 07/2010 - 08/2004
2	Communicable Diseases (Infectious Diseases) 03/2022 - 01/2022
2	Erythema Nodosum 01/2022 - 12/2017
2	Asymptomatic Infections 01/2021 - 12/2020
2	Coinfection 01/2020 - 09/2013
2	Chagas Cardiomyopathy 01/2020 - 06/2017
2	Lepromatous Leprosy 11/2017 - 01/2016
2	Necrosis 01/2015 - 02/2007
1	Chikungunya Fever 04/2022
1	Arthralgia (Joint Pain) 04/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Paucibacillary Leprosy 10/2021
1	Granuloma Annulare 10/2021
1	Granuloma 10/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Neuralgia (Stump Neuralgia) 01/2020
1	Pain (Aches) 01/2020
1	Nociceptive Pain 01/2020
1	Clinical Deterioration 01/2020
1	Tuberculoid Leprosy 11/2017
1	Demyelinating Diseases (Demyelinating Disease) 03/2016
1	Neuritis (Polyneuritis) 03/2016
1	Bites and Stings (Sting) 01/2016
1	Heart Diseases (Heart Disease) 01/2016
1	Chagas Disease (American Trypanosomiasis) 01/2016
1	Borderline Leprosy 01/2016
1	Hypersensitivity (Allergy) 07/2010
1	Leishmaniasis 10/2005

Drug/Important Bio-Agent (IBA)

10	AntigensIBA 03/2022 - 08/2004
9	CytokinesIBA 04/2022 - 01/2015
7	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2016
5	Interleukin-10 (Interleukin 10)IBA 03/2022 - 01/2015
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2022 - 11/2011
4	Interleukin-6 (Interleukin 6)IBA 04/2022 - 01/2015
4	EnzymesIBA 03/2022 - 03/2016
4	LipidsIBA 10/2021 - 01/2017
3	InterferonsIBA 04/2022 - 09/2013
3	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 04/2022 - 11/2017
3	ImmunosorbentsIBA 03/2022 - 12/2017
3	Pharmaceutical PreparationsIBA 01/2021 - 11/2011
3	AntibodiesIBA 01/2018 - 10/2005
2	Heme Oxygenase-1IBA 12/2022 - 11/2017
2	Proteins (Proteins, Gene)FDA Link 12/2022 - 11/2017
2	Interleukin-4 (Interleukin 4)IBA 03/2022 - 02/2007
2	RNA (Ribonucleic Acid)IBA 10/2021 - 11/2019
2	Rifampin (Rifampicin)FDA LinkGeneric 01/2021 - 04/2018
2	Interleukin-15 (Interleukin 15)IBA 01/2021 - 11/2019
2	IronIBA 01/2018 - 11/2017
2	Thalidomide (Thalomid)FDA Link 01/2016 - 11/2011
1	ArginaseIBA 12/2022
1	LigandsIBA 04/2022
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2022
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 04/2022
1	ChemokinesIBA 04/2022
1	Interferon Type IIBA 01/2022
1	KynurenineIBA 01/2022
1	Messenger RNA (mRNA)IBA 10/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	Dapsone FDA Link 01/2021
1	Clofazimine (Lamprene)FDA Link 01/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	BCG Vaccine FDA Link 04/2018
1	Immunoglobulin M (IgM)IBA 01/2018
1	InflammasomesIBA 01/2018
1	Immunoglobulin IsotypesIBA 01/2018
1	Immunoglobulin G (IgG)IBA 01/2018
1	Transferrin Receptors (Transferrin Receptor)IBA 11/2017
1	Hemoglobins (Hemoglobin)IBA 11/2017
1	HaptoglobinsIBA 11/2017
1	Triglycerides (Triacylglycerol)IBA 06/2017
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 06/2017
1	GangliosidesIBA 03/2016
1	Interleukin-23 (Interleukin 23)IBA 03/2016
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 03/2016
1	Interleukin-8 (Interleukin 8)IBA 03/2016
1	InterleukinsIBA 03/2016
1	2',5'-Oligoadenylate Synthetase (2',5' Oligoadenylate Synthetase)IBA 01/2016
1	Cysteine Proteinase InhibitorsIBA 07/2010
1	Serine (L-Serine)FDA Link 07/2010
1	Polymethyl Methacrylate (Sol)IBA 07/2010
1	cyclopropapyrroloindoleIBA 07/2010
1	lipophosphonoglycanIBA 03/2007
1	VaccinesIBA 03/2007
1	Monoclonal AntibodiesIBA 03/2007
1	Interferon-gamma (Interferon, gamma)IBA 02/2007
1	Interleukin-12 (IL 12)IBA 02/2007
1	factor AIBA 02/2007
1	Transforming Growth Factor beta (TGF-beta)IBA 10/2005
1	DNA (Deoxyribonucleic Acid)IBA 08/2004

Therapy/Procedure

7	Therapeutics 01/2021 - 11/2011
2	Chemoprevention 12/2022 - 04/2018
2	Highly Active Antiretroviral Therapy (HAART) 01/2020 - 09/2013
1	Cardiac Rehabilitation 01/2020
1	Aftercare (After-Treatment) 11/2019
1	Treatment Delay 01/2018